271 related articles for article (PubMed ID: 32601646)
1. Prevalence of toxoplasmosis, rubella, cytomegalovirus, and herpes (TORCH) infections among women attending the antenatal care clinic, maternity hospital in Abha, Southwestern Saudi Arabia.
Al-Hakami AM; Paul E; Al-Abed F; Alzoani AA; Shati AA; Assiri MI; Qasim AA; Riaz F; Moosa RA; Chandramoorthy HC
Saudi Med J; 2020 Jul; 41(7):757-762. PubMed ID: 32601646
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of torch infections and its associated poor outcome in high-risk pregnant women of Central India: Time to think for prevention strategies.
Manjunathachar HV; Singh KN; Chouksey V; Kumar R; Sharma RK; Barde PV
Indian J Med Microbiol; 2020; 38(3 & 4):379-384. PubMed ID: 33154250
[TBL] [Abstract][Full Text] [Related]
3. TORCH screening used appropriately in China?─three years results from a teaching hospital in northwest China.
Wang LC; Yan F; Ruan JX; Xiao Y; Yu Y
BMC Pregnancy Childbirth; 2019 Dec; 19(1):484. PubMed ID: 31818265
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of TORCH infections in women of childbearing age in Croatia.
Vilibic-Cavlek T; Ljubin-Sternak S; Ban M; Kolaric B; Sviben M; Mlinaric-Galinovic G
J Matern Fetal Neonatal Med; 2011 Feb; 24(2):280-3. PubMed ID: 20476874
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of Toxoplasma gondii, rubella and cytomegalovirus among pregnant women in western region of Turkey.
Tamer GS; Dundar D; Caliskan E
Clin Invest Med; 2009 Feb; 32(1):E43-7. PubMed ID: 19178878
[TBL] [Abstract][Full Text] [Related]
6. Screening for TORCH infections in pregnant women: a report from Delhi.
Kaur R; Gupta N; Nair D; Kakkar M; Mathur MD
Southeast Asian J Trop Med Public Health; 1999 Jun; 30(2):284-6. PubMed ID: 10774696
[TBL] [Abstract][Full Text] [Related]
7. [Investigation on TORCH infections for pregnant women and neonates in Yan'an City].
Zhang QQ; Cheng JZ
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2012 Aug; 24(4):386, 392. PubMed ID: 23236780
[TBL] [Abstract][Full Text] [Related]
8. Screening cytomegalovirus, rubella and toxoplasma infections in pregnant women with unknown pre-pregnancy serological status.
Karacan M; Batukan M; Cebi Z; Berberoglugil M; Levent S; Kır M; Baksu A; Ozel E; Camlıbel T
Arch Gynecol Obstet; 2014 Dec; 290(6):1115-20. PubMed ID: 25027818
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of toxoplasma gondii, rubella virus, cytomegalovirus herpes simplex virus (TORCH) and syphilis in Jamaican pregnant women.
Prabhakar P; Bailey A; Smikle MF; McCaw-Binns A; Ashley D
West Indian Med J; 1991 Dec; 40(4):166-9. PubMed ID: 1664562
[TBL] [Abstract][Full Text] [Related]
10. Seroepidemiology of TORCH Infections among 1.7 Million Women of Childbearing Age in Rural China: A Population-Based Cross-Sectional Study.
Qin X; Zhang S; Liu H; Cheng G; Liu Y; Hu M; Liu N; Zhang M
Am J Trop Med Hyg; 2021 Sep; 105(5):1202-1209. PubMed ID: 34544045
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of Toxoplasma gondii, rubella and cytomegalovirus among pregnant women in southern Turkey.
Ocak S; Zeteroglu S; Ozer C; Dolapcioglu K; Gungoren A
Scand J Infect Dis; 2007; 39(3):231-4. PubMed ID: 17366053
[TBL] [Abstract][Full Text] [Related]
12. Seroepidemiology of TORCH antibodies in the reproductive-aged women in China.
Qi Y; Zhu S; Li C; Wu H; Yue H; Zhang Y; Zhu B; Ma J; Feng Z; Kong H; Cai X; Ruan Q
Eur J Obstet Gynecol Reprod Biol; 2020 Nov; 254():114-118. PubMed ID: 32957008
[TBL] [Abstract][Full Text] [Related]
13. Seasonal influence on TORCH infection and analysis of multi-positive samples with indirect immunofluorescence assay.
Chen L; Liu J; Shi L; Song Y; Song Y; Gao Y; Dong Y; Li L; Shen M; Zhai Y; Cao Z
J Clin Lab Anal; 2019 May; 33(4):e22828. PubMed ID: 30666721
[TBL] [Abstract][Full Text] [Related]
14. Association between TORCH infection and lupus anticoagulant antibody in pregnant women with recurrent abortion.
Fatah HR
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(13):162-166. PubMed ID: 38158672
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of preconception TORCH infections and its influential factors: evidence from over 2 million women with fertility desire in southern China.
Han L; Li R; Xiong W; Hu Y; Wu J; Liu X; Nie H; Qin W; Ling L; Li M
BMC Womens Health; 2023 Aug; 23(1):425. PubMed ID: 37563634
[TBL] [Abstract][Full Text] [Related]
16. The epidemiology and disease burden of congenital TORCH infections among hospitalized children in China: A national cross-sectional study.
Zhang L; Wang X; Liu M; Feng G; Zeng Y; Wang R; Xie Z
PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010861. PubMed ID: 36240247
[TBL] [Abstract][Full Text] [Related]
17. Seroconversion and seroprevalence of TORCH infections in a pregnant women cohort study, Mombasa, Kenya, 2017-2019.
Hunsperger E; Osoro E; Munyua P; Njenga MK; Mirieri H; Kikwai G; Odhiambo D; Dayan M; Omballa V; Agogo GO; Mugo C; Widdowson MA; Inwani I
Epidemiol Infect; 2024 Feb; 152():e68. PubMed ID: 38305089
[TBL] [Abstract][Full Text] [Related]
18. [Prevalence of infectious agents in indigenous women of childbearing age in Venezuela].
Monsalve-Castillo FM; Costa-León LA; Castellano ME; Suárez A; Atencio RJ
Biomedica; 2012; 32(4):519-26. PubMed ID: 23715227
[TBL] [Abstract][Full Text] [Related]
19. Is screening of TORCH worthwhile in women with bad obstetric history: an observation from eastern Nepal.
Kumari N; Morris N; Dutta R
J Health Popul Nutr; 2011 Feb; 29(1):77-80. PubMed ID: 21528793
[TBL] [Abstract][Full Text] [Related]
20. The Screening of
Nabizadeh E; Ghotaslou A; Salahi B; Ghotaslou R
Infect Dis Obstet Gynecol; 2022; 2022():4490728. PubMed ID: 35046632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
